EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 42 / No 3 (Mars 2026) Med Sci (Paris), 42 3 (2026) 270-279 References
Organoïdes
Open Access
Issue
Med Sci (Paris)
Volume 42, Number 3, Mars 2026
Organoïdes
Page(s) 270 - 279
Section M/S Revues
DOI https://doi.org/10.1051/medsci/2026035
Published online 20 March 2026
  1. Luce E, Messina A, Caillaud A, et al. Les organoïdes hépatiques : quels sont les enjeux ? Med Sci (Paris) 2021 ; 37 : 902–9. [Google Scholar]
  2. Yu Y, Liu H, Ikeda Y, et al. Hepatocyte-like cells differentiated from human induced pluripotent stem cells: Relevance to cellular therapies. Stem Cell Res 2012 ; 9 : 196–207. [Google Scholar]
  3. Igarashi R, Oda M, Okada R, et al. Generation of human adult hepatocyte organoids with metabolic functions. Nature 2025 ; 641 : 1248–57. [Google Scholar]
  4. Kuse Y, Matsumoto S, Tsuzuki S, et al. Placenta-derived factors contribute to human iPSC-liver organoid growth. Nat Commun 2025 ; 16 : 2493. [Google Scholar]
  5. Osonoi S, Takebe T. Organoid-guided precision hepatology for metabolic liver disease. J Hepatol 2024 ; 80 : 805–21. [Google Scholar]
  6. Jungermann K, Katz N. Functional specialization of different hepatocyte populations. Physiol Rev 1989 ; 69 : 708–64. [Google Scholar]
  7. Reza HA, Santangelo C, Iwasawa K, et al. Multi-zonal liver organoids from human pluripotent stem cells. Nature 2025 ; 641 : 1258–67. [Google Scholar]
  8. Harrison SP, Siller R, Tanaka Y, et al. Scalable production of tissue-like vascularized liver organoids from human PSCs. Exp Mol Med 2023 ; 55 : 2005–24. [Google Scholar]
  9. Kim HY, Lee W, Liu X, et al. Protocol to generate human liver spheroids to study liver fibrosis induced by metabolic stress. STAR Protocols 2024 ; 5 : 103111. [Google Scholar]
  10. Guan Y, Enejder A, Wang M, et al. A human multi-lineage hepatic organoid model for liver fibrosis. Nat Commun 2021 ; 12 : 6138. [Google Scholar]
  11. Collin De l’Hortet A, Gilgenkrantz H. L’émergence des modèles miniatures de foie gras humain en 3D générés en laboratoire. Med Sci (Paris) 2020 ; 36 : 261–3. [Google Scholar]
  12. Perréard M, Florent R, Thorel L, et al. Les organoïdes dérivés de tumeurs (ou tumoroïdes), des outils de choix pour la médecine de précision en oncologie. Med Sci (Paris) 2022 ; 38 : 888–95. [Google Scholar]
  13. Giron-Michel J, Padelli M, Oberlin E, et al. State-of-the-art liver cancer organoids: modeling cancer stem cell heterogeneity for personalized treatment. BioDrugs 2025 ; 39 : 237–60. [Google Scholar]
  14. Takebe T, Sekine K, Kimura M, et al. Massive and reproducible production of liver buds entirely from human pluripotent stem cells. Cell Reports 2017 ; 21 : 2661–70. [Google Scholar]
  15. Kim HJ, Kim G, Chi KY, et al. Generation of multilineage liver organoids with luminal vasculature and bile ducts from human pluripotent stem cells via modulation of Notch signaling. Stem Cell Res Ther 2023 ; 14 : 19. [Google Scholar]
  16. Velazquez JJ, LeGraw R, Moghadam F, et al. Gene regulatory network analysis and engineering directs development and vascularization of multilineage human liver organoids. Cell Systems 2021 ; 12 : 41–55.e11. [Google Scholar]
  17. Yan J, Ye Z, Lu Y, et al. 3D bioprinting lobule-like hepatorganoids with induced vascularization for orthotopic implantation. Materials Today Bio 2025 ; 31 : 101515. [Google Scholar]
  18. Deguchi S, Takayama K. State-of-the-art liver disease research using liver-on-a-chip. Inflamm Regen 2022 ; 42 : 62. [Google Scholar]
  19. Kim HJ, Kim G, Chi KY, et al. In Vitro Generation of luminal vasculature in liver organoids: from basic vascular biology to vascularized hepatic organoids. Int J Stem Cells 2023 ; 16 : 1–15. [Google Scholar]
  20. Shinozawa T, Kimura M, Cai Y, et al. High-fidelity drug-induced liver injury screen using human pluripotent stem cell–derived organoids. Gastroenterology 2021 ; 160 : 831–46.e10. [Google Scholar]
  21. Wu X, Jiang D, Yang Y, et al. Modeling drug-induced liver injury and screening for anti-hepatofibrotic compounds using human PSC-derived organoids. Cell Regen 2023 ; 12 : 6. [Google Scholar]
  22. Wu X, Jiang D, Wang Y, et al. Modeling metabolic-associated steatohepatitis with human pluripotent stem cell-derived liver organoids. Hepatol Commun 2024 ; 8 : e0585. [Google Scholar]
  23. Sgodda M, Gebel E, Dignas L, et al. iPSC-based hepatic organoids reveal a heterozygous MYO5B variant as driver of intrahepatic cholestasis. Hepatol Comm 2025 ; 9 : e0812. [Google Scholar]
  24. Yoon Y, Gong SC, Kim MY, et al. Generation of fibrotic liver organoids using hepatocytes, primary liver sinusoidal endothelial cells, hepatic stellate cells, and macrophages. Cells 2023 ; 12 : 2514. [Google Scholar]
  25. Coll M, Perea L, Boon R, et al. Generation of hepatic stellate cells from human pluripotent stem cells enables in vitro modeling of liver fibrosis. Cell Stem Cell 2018 ; 23 : 101–13.e7. [Google Scholar]
  26. Luce E, Steichen C, Allouche M, et al. In vitro recovery of FIX clotting activity as a marker of highly functional hepatocytes in a hemophilia B iPSC model. Hepatology 2022 ; 75 : 866–80. [Google Scholar]
  27. Guan Y, Xu D, Garfin PM, et al. Human hepatic organoids for the analysis of human genetic diseases. JCI Insight 2017 ; 2 : e94954. [Google Scholar]
  28. Hendriks D, Brouwers JF, Hamer K, et al. Engineered human hepatocyte organoids enable CRISPR-based target discovery and drug screening for steatosis. Nat Biotechnol 2023 ; 41 : 1567–81. [Google Scholar]
  29. Maschmeyer I, Lorenz AK, Schimek K, et al. A four-organ-chip for interconnected long-term co-culture of human intestine, liver, skin and kidney equivalents. Lab Chip 2015 ; 15 : 2688–99. [CrossRef] [PubMed] [Google Scholar]
  30. Lucchetti M, Aina KO, Grandmougin L, et al. An Organ-on-chip platform for simulating drug metabolism along the gut–liver axis. Adv Healthc Mater 2024 ; 13 : 2303943. [Google Scholar]
  31. Tao T, Deng P, Wang Y, et al. Microengineered multi-organoid system from hiPSCs to recapitulate human liver-islet axis in normal and type 2 diabetes. Adv Sci (Weinh) 2022 ; 9 : 2103495. [Google Scholar]
  32. Sampaziotis F, Muraro D, Tysoe OC, et al. Cholangiocyte organoids can repair bile ducts after transplantation in the human liver. Science 2021 ; 371 : 839–46. [CrossRef] [PubMed] [Google Scholar]
  33. Hussein M, Pasqua M, Pereira U, et al. Microencapsulated hepatocytes differentiated from human induced pluripotent stem cells: optimizing 3d culture for tissue engineering applications. Cells 2023 ; 12 : 865. [Google Scholar]
  34. Sakiyama R, Blau BJ, Miki T. Clinical translation of bioartificial liver support systems with human pluripotent stem cell-derived hepatic cells. World J Gastroenterol 2017 ; 23 : 1974–9. [Google Scholar]
  35. Selden C, Bundy J, Erro E, et al. A clinical-scale bioartificial liver, developed for GMP, improved clinical parameters of liver function in porcine liver failure. Sci Rep 2017 ; 7 : 14518. [Google Scholar]
  36. Li Y, Nie Y, Yang X, et al. Integration of Kupffer cells into human iPSC-derived liver organoids for modeling liver dysfunction in sepsis. Cell Reports 2024 ; 43 : 113918. [Google Scholar]
  37. Soussi FEA, Brusilovsky M, Buck E, et al. Autologous organoid-t cell co-culture platform for modeling of immune-mediated drug-induced liver injury. Adv Sci (Weinh) 2025 ; 12 : e08584. [Google Scholar]
  38. Lewis DI. Animal experimentation: implementation and application of the 3Rs. Emerg Top Life Sci 2019 ; 3 : 675–9. [Google Scholar]
  39. Liu Y, Zhou Y, Ahodantin J, et al. Generation and characterization of mature hepatocyte organoids for liver metabolic studies. J Cell Sci 2024 ; 137 : jcs261961. [Google Scholar]
  40. Maramraju S, Kowalczewski A, Kaza A, et al. AI-organoid integrated systems for biomedical studies and applications. Bioeng Transl Med 2024 ; 9 : e10641. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.